Improving the quality of US drug patents through international awareness

被引：5

作者：

Bloomfield, Doni

Lu, Zhigang

Kesselheim, Aaron S. ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Program Regulat Therapeut & Law PORTAL, 75 Francis St, Boston, MA 02115 USA

来源：

BMJ-BRITISH MEDICAL JOURNAL | 2022年 / 377卷

关键词：

D O I：

10.1136/bmj-2021-068172

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页数：4

共 26 条

[1] Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For Decades [J].

Amin, Tahir ;

Kesselheim, Aaron S. .

HEALTH AFFAIRS, 2012, 31 (10) :2286-2294

[2]

[Anonymous], 2021, LETT FDA USPTO

[3]

[Anonymous], PATSTAT DATABASE

[4]

[Anonymous], 2013, EUROPEAN SEARCH REPO

[5]

[Anonymous], 2007, KSR Int'l Co. v. Teleflex Inc., 550U.S.398,406-07,413-19 (

[6]

[Anonymous], 2022, 37 C.F.R. 1.520

[7]

[Anonymous], 2018, U.S.C.

[8] Extending Drug Monopolies by Patenting Safe Drug Use [J].

Bloomfield, Doni ;

Walsh, Bryan S. ;

Kesselheim, Aaron S. .

JAMA INTERNAL MEDICINE, 2022, 182 (03) :245-246

[9]

Chien C., 2018, Ariz. St. LJ, V50, P71

[10]

Chien CV., 2019, IOWA L. REV. ONLINE, V104, P1

← 1 2 3 →